Dr Reddy's acquires 6 OTC brands from Ducere Pharma in US

With this, the Hyderabad based pharma major has entered the branded consumer health market in the US

Dr Reddy's facility
Dr Reddy’s facility
BS B2B Bureau Hyderabad
Last Updated : May 26 2016 | 4:45 PM IST
Dr Reddy’s Laboratories Ltd has acquired six over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories from the US-based Ducere Pharma. Brands that the company has acquired include including Doan’s, Bufferin, Nupercainal ointment, Cruex nail gel, Comtrex, and Myoflex.
 
“These legacy products enjoy strong brand equity built over several decades. We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US,” explained Alok Sonig, executive vice president and head of Dr Reddy’s in the US
 
According to Sonig, Dr Reddy’s will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels. Sonig commends the marketing and brand-building efforts of Ducere Pharma, recognising the organisation’s role in successfully revitalising the brands through improved distribution and promotional efforts.
 
“We think Dr Reddy’s is well-positioned to continue the successful growth of these brands. We feel confident that our brand-loyal consumers will be well-served by the deal,” said Samuel Hines of Casla Capital Management LLC.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 26 2016 | 3:41 PM IST

Next Story